Bayer settles Roundup cancer lawsuits for up to $10.9 billion

FRANKFURT (Reuters) - Bayer AG agreed to settle U.S. lawsuits claiming that its widely-used weedkiller Roundup caused cancer for as much as $10.9 billion (£8.1-8.7 billion) after more than a year of talks, resolving litigation that has hit the company's share price. The German drugs and pesticides maker has come to terms with about 75% of the current Roundup plaintiffs, involving about 125,000 filed and unfiled claims overall, it said in a statement on Wednesday.The settled cases account for..